First Aid Antibiotic (Bacitracin)

First Aid Antibiotic (Bacitracin) represents a over-the-counter branded aminoglycoside antibacterial entry registered by HyVee Inc with package codes 42507-536, 42507-067. Reviewed against 2026-05-12 FDA SPL standards (400 [USP'U]/g / 3.5 mg/g Ointment; 500 [USP'U]/g Ointment), clinical deployment addresses Uses first aid to help prevent infection in: ; minor cuts ; scrapes ; burns

First Aid Antibiotic achieves therapeutic action via Bacitracin, engaging aminoglycoside antibacterial physiological pathways with class-characteristic hepatorenal disposition. Manufactured in 400 [USP'U]/g / 3.5 mg/g Ointment; 500 [USP'U]/g Ointment (registered by HyVee Inc, NDC 42507-536, 42507-067), pharmacists evaluate FDA Orange Book therapeutic equivalence when comparing branded First Aid Antibiotic ($35.09 retail) with generic Bacitracin ($13.09 low cash).

With Negligible circulating terminal half-life following local First Aid Antibiotic (Bacitracin) application residence kinetics and < 5% transdermal or mucosal systemic uptake from First Aid Antibiotic (Bacitracin) bioavailability, First Aid Antibiotic (Bacitracin) undergoes local esterase/enzymatic cleavage of first aid antibiotic (bacitracin) with minimal hepatic cytochrome burden and establishes therapeutic activity over initial local symptom modulation in 30–90 minutes; full tissue response over 1–3 weeks (first aid antibiotic (bacitracin)).

Standard adult regimens span 400 [USP'U]/g / 3.5 mg/g Ointment, 500 [USP'U]/g Ointment, 400 [iU]/g / 35 mg/g Gel, 400 U/g / 3.5 mg/g Liquid, 400 [USP'U]/g / .0035 g/g Ointment. Prescribers screen specifically against contraindicated in patients with prior serious allergic response to first aid antibiotic (bacitracin) (ndc 42507-536); severe baseline organ impairment where bacitracin accumulation exceeds safe therapeutic margins, while community micro-logs most frequently note diarrhea (8.1% of reports), nausea (7.1% of reports), headache (4.8% of reports).